Search Prime Grants

U01CA233100

Cooperative Agreement

Overview

Grant Description
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer.
Funding Goals
NOT APPLICABLE
Place of Performance
Boston, Massachusetts 02215 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 401% from $841,459 to $4,219,302.
Dana-Farber Cancer Institute was awarded Molecular and immune drivers of immunotherapy responsiveness in prostate cancer Cooperative Agreement U01CA233100 worth $4,219,302 from National Cancer Institute in September 2018 with work to be completed primarily in Boston Massachusetts United States. The grant has a duration of 5 years and was awarded through assistance program 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot. The Cooperative Agreement was awarded through grant opportunity Immuno-Oncology Translational Network (IOTN): Cancer Immunotherapy Research Projects (U01).

Status
(Complete)

Last Modified 2/20/24

Period of Performance
9/19/18
Start Date
8/31/23
End Date
100% Complete

Funding Split
$4.2M
Federal Obligation
$0.0
Non-Federal Obligation
$4.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01CA233100

Subgrant Awards

Disclosed subgrants for U01CA233100

Transaction History

Modifications to U01CA233100

Additional Detail

Award ID FAIN
U01CA233100
SAI Number
U01CA233100-2255218676
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
DPMGH9MG1X67
Awardee CAGE
5E915
Performance District
MA-07
Senators
Edward Markey
Elizabeth Warren

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $5,058,748 100%
Modified: 2/20/24